WBA - CVS Walgreens Boots Among Firms Receiving Warning Letter Against Selling Unapproved Eye Products | Benzinga
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating federal law.
The companies include CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance Inc (NASDAQ: WBA), DR Vitamin Solutions, Natural Ophthalmics, Inc, OcluMed, Similasan AG/Similasan USA, TRP Company Inc, Boiron Inc.
Eye products addressed in the eight warning letters are illegally marketed to treat conditions such as conjunctivitis ("pink ...